©2013 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Nov 16, 2013; 5(11): 551-558
Published online Nov 16, 2013. doi: 10.4253/wjge.v5.i11.551
Published online Nov 16, 2013. doi: 10.4253/wjge.v5.i11.551
Table 2 Risk factors for rebleeding
| Risk factors | Univariate Log-rank test | Multivariate | ||
| P | HR | 95%CI | P | |
| Age > 70 yr | 0.037 | 2.1 | 1.2-6.1 | 0.05 |
| Gender | 0.800 | - | - | - |
| Overt OGIB presentation | 0.130 | - | - | - |
| Hb < 8.0 g/dL | 0.027 | 2.7 | 1.9-6.3 | 0.03 |
| Blood units transfused | 0.180 | - | - | - |
| Transfusions requirement | 0.020 | - | - | - |
| T ≥ 2 blood units | 0.023 | - | - | - |
| NSAID intake | 0.900 | - | - | - |
| Significant lesions in CE | 0.036 | 2.4 | 1.1-5.8 | 0.01 |
| Specific treatment carried out | 0.500 | - | - | - |
- Citation: Cañas-Ventura A, Márquez L, Bessa X, Dedeu JM, Puigvehí M, Delgado-Aros S, Ibáñez IA, Seoane A, Barranco L, Bory F, Andreu M, González-Suárez B. Outcome in obscure gastrointestinal bleeding after capsule endoscopy. World J Gastrointest Endosc 2013; 5(11): 551-558
- URL: https://www.wjgnet.com/1948-5190/full/v5/i11/551.htm
- DOI: https://dx.doi.org/10.4253/wjge.v5.i11.551